期刊文献+

脂质体介导c-myc反义寡核苷酸对乳腺癌MCF-7细胞生物学行为的影响 被引量:4

Effect of liposome-mediated c-myc antisense oligodeoxynucleotide on biological behaviors of breast cancer MCF-7cells
下载PDF
导出
摘要 目的研究c-myc反义寡核苷酸(ASODN)经脂质体LipfectAMINETM(LR)介导转染对MCF-7细胞中c-myc蛋白表达及细胞增殖、凋亡的影响。方法用四甲基偶氮唑盐法(MTT法)评价脂质体介导c-myc ASODN对细胞增殖的影响;免疫细胞化学ABC方法检测转染前后c-myc蛋白表达;流式细胞仪(FCM)定量分析细胞凋亡。结果ASODN/LR转染与正义、错义寡核苷酸相比,显著抑制MCF-7细胞增殖(P<0.01)。FCM分析结果显示,转染后可见明显细胞凋亡峰,72h相点细胞凋亡率达(28.76±2.09)%。免疫细胞化学显示c-myc蛋白水平明显降低,阳性表达率为(21.40±1.16)%。结论LR介导c-myc ASODN能明显抑制MCF-7细胞增殖、诱导细胞凋亡和下调c-myc蛋白水平。 Objective: To investigate the effects of liposome (LipfectAMINETM, namely LR)-mediated c-myc antisense oligodeoxynucleotide(ASODN) on cell proliferation, c-myc protein expression, and apoptosis of MCF-7 cells. Methods: Cell proliferation was measured by MTT assay. Expression of c-myc protein was measured by immunocytochemistry before and after transfection. Apoptosis of cells was detected by flow cytometry. Results: Transfection of ASODN/LR markedly inhibited the proliferation of MCF-7 cells compared with sense and missense ODN( P〈0.01 ). FCM analysis showed that there appeared an obvious apoptosis peak after transfection. The apoptosis rate was maximum (28.76±2.09)% at 72 h. The immunocytochemistry staining showed that c-myc protein expression was suppressed significantly(21.4 ~ 1. 16)%. Conclusion: Liposome-mediated c-myc ASODN can evidently inhibit cell proliferation, down-regulate c-myc protein expression,and induce apoptosis of MCF-7 cells.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第1期17-20,共4页 Tumor
基金 四川省教育厅自然基金重点资助项目(编号:2002A068)
关键词 基因 myc 寡核苷酸类 反义 脂质体 乳腺肿瘤 细胞学 基N表达 凋亡 Genes,myc Oligonucleotides,antisense Liposomes Breast neoplasms,cytology Gene expression Apoptosis
  • 相关文献

参考文献8

  • 1朱军,孙泽林,戚晓渊,李建珉,程爱国.腺病毒介导的p16基因对TJ899细胞系活性的影响[J].中华神经外科疾病研究杂志,2004,3(4):341-343. 被引量:2
  • 2陈小强,龚兴国,梁倩,史锋,陈勇.三种藻胆蛋白对人乳腺癌Bcap-37细胞的光动力杀伤效果[J].浙江大学学报(理学版),2005,32(4):438-441. 被引量:7
  • 3余小平,糜漫天,朱俊东.三羟异黄酮对MCF-7/HER-2乳腺癌细胞VEGF表达变化的影响[J].肿瘤,2005,25(4):307-310. 被引量:1
  • 4AKIE K,DOSAKA-AKITA H,MURAKIMA A,et al.A combination treatment of c-myc antisense DNA with all-transretinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer[J].Antisense Nucleic Acid Drug Dev,2000,10:243-249. 被引量:1
  • 5EBINUMA H,SAITO H,SAITO Y,et al.Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells[J].Int J Oncol,1999,15:991-999. 被引量:1
  • 6WEBB M S,TORTORA N,CREMESE M,et al.Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-cmyc ongone in cynomolgus monkeys[J].Antisense Nucleic Acid Drug Dev,2001,11(3):155-163. 被引量:1
  • 7CAROLL J S,SWARBRICK A,MUSGROVE E A,et al.Mechanisms of growth array by c-cmyc antisense oligonucleotides in MCF-7 breast cancer cells:implications for the antiproliferative effects of antiestrogens [J].Cancer Res,2002,62:3126-3131. 被引量:1
  • 8CONG Y S,WEN J,BACCHETTI S.The human telomerase catalytic subunit hTRRT:organization of the gene and characterization of the promoter[J].Hum Mol Genet,1999,8:137-142. 被引量:1

二级参考文献31

  • 1蔡心涵,何立明,蒋家伦,郁琳琳,徐芝敏,郑树.螺旋藻藻蓝蛋白对癌激光疗法增敏作用的实验研究[J].中国海洋药物,1995,14(1):15-18. 被引量:48
  • 2Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing [J]. Cancer Res, 1995, 55(20): 4531-4535. 被引量:1
  • 3Luca M, Xie S, Gutman M. Abnormalities in the CDKN2 (p16INK4/MTS-1) gene in human melanoma cells: Relevance to tumor growth and metastasis [J]. Oncogene, 1995, 11(7): 1399-1402. 被引量:1
  • 4Liebermann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways [J]. Oncogene, 1995, 11(1): 199-210. 被引量:1
  • 5Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTSLgene is frequently associated with aberrant DNA methylation in all common human cancers [J]. Cancer Res, 1995, 55(20): 4525-4530. 被引量:1
  • 6Larsen CJ. p16INK4: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression [J]. Oncogene, 1996, 12(10): 2041-2044. 被引量:1
  • 7Igaki H, Sasaki H, Tachimori Y, et al. Mutation frequency of p16/CDKN2 gene in primary cancers in the upper digestive tract [J]. Cancer Res, 1995, 55(15): 3421-3423. 被引量:1
  • 8金丕焕 苏炳华 贺佳.医用SAS统计分析 [M](第1版)[M].上海:复旦大学出版社,2002.142-143. 被引量:1
  • 9Polkowski K, Mazurek AP. Biological properties of genistein. A review of in vitro and in vivo data[J]. Acta Pol Pharm, 2000,57:135-155. 被引量:1
  • 10Kerbel RS. Tumor angiogenesis: past, present,and the near future. [J]. Carcinogenesis, 2000,21 :505-515. 被引量:1

共引文献7

同被引文献43

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部